US equities
|
NVDA
$237.18
▲+1.38%
MU
$1,059.79
▼-1.41%
SPCX
$164.85
▲+3.71%
TSLA
$375.56
▲+1.34%
MSFT
$527.98
▲+2.02%
INTC
$116.02
▼-2.77%
SNDK
$1,716.96
▼-0.18%
AMD
$627.67
▼-0.98%
NVDA
$237.18
▲+1.38%
MU
$1,059.79
▼-1.41%
SPCX
$164.85
▲+3.71%
TSLA
$375.56
▲+1.34%
MSFT
$527.98
▲+2.02%
INTC
$116.02
▼-2.77%
SNDK
$1,716.96
▼-0.18%
AMD
$627.67
▼-0.98%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Ironwood Pharmaceuticals, Inc. - Class A Common Stock
(NQ:
IRWD
)
3.575
-0.065 (-1.79%)
Delayed Quote
Updated: 10:02 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ironwood Pharmaceuticals, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Ironwood Pharmaceuticals Reports First Quarter 2021 Results
May 06, 2021
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Ironwood Pharmaceuticals to Host First Quarter 2021 Investor Update Call
April 22, 2021
From
Ironwood Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
